IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption.
Langer V, Vivi E, Regensburger D, Winkler TH, Waldner MJ, Rath T, Schmid B, Skottke L, Lee S, Jeon NL, Wohlfahrt T, Kramer V, Tripal P, Schumann M, Kersting S, Handtrack C, Geppert CI, Suchowski K, Adams RH, Becker C, Ramming A, Naschberger E, Britzen-Laurent N, Stürzl M.
Langer V, et al. Among authors: sturzl m.
J Clin Invest. 2019 Nov 1;129(11):4691-4707. doi: 10.1172/JCI124884.
J Clin Invest. 2019.
PMID: 31566580
Free PMC article.
Clinical Trial.